|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 45/00 | (2006.01) |
| A61K 31/437 | (2013.01) | ||
| A61P 25/00 | (2006.01) | ||
| A61K 31/196 | (2013.01) | ||
| A61K 31/196 | (2006.01) | ||
| A61K 45/00 | (2013.01) | ||
| A61K 31/437 | (2006.01) | ||
| A61P 25/00 | (2018.01) |
| (11) | Number of the document | 3785733 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20195373.4 |
| Date of filing the European patent application | 2018-11-06 | |
| (97) | Date of publication of the European application | 2021-03-03 |
| (45) | Date of publication and mention of the grant of the patent | 2022-01-05 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201762582141 P | 2017-11-06 | US | |
| 17200219 | 2017-11-06 | EP | |
| 201862663647 P | 2018-04-27 | US | |
| 18169952 | 2018-04-27 | EP |
| (72) |
Durham, Lynn , CH
|
| (73) |
Stalicla S.A. ,
Avenue de Sécheron 15, 1202 Geneva,
CH
|
| (54) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF AUTISM |
| PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF AUTISM |